Gupta Krishna P, Singh Jaya
Environmental Carcinogenesis Division, Industrial Toxicology Research Center, Lucknow, India.
Toxicol Sci. 2004 May;79(1):47-55. doi: 10.1093/toxsci/kfh098. Epub 2004 Feb 19.
Almost all the polycyclic aromatic hydrocarbons (PAHs) require metabolic activation to exert their carcinogenic activity. Environmental carcinogen [(3)H] benzo[a]pyrene (BP) is carcinogenic only after its metabolic transformation to a reactive intermediate, which can then bind to cellular macromolecules. Inhibition of dimethylbenz anthracene- (DMBA-) DNA binding generally accompanied inhibition of tumor initiation as most inhibitors of initiation interfere with the metabolic activation of the initiator. The importance of carcinogen-DNA interaction and the enzymes involved in the metabolism of carcinogenic polycyclic hydrocarbons has led to a search for inhibitors that would be useful in modifying the cancer-causing effects of the PAHs. We tested the effect of calcium glucarate (Cag), a naturally occurring nontoxic compound, on carcinogen metabolism and DNA interaction. Cag inhibited [(3)H] BP binding to both calf thymus DNA in vitro and to epidermal DNA in vivo. Application of Cag to mouse skin caused a dose-dependent inhibition of [(3)H] BP binding to epidermal DNA. To establish the relevance of the in vivo results to the in vitro situation, we followed the in vitro effect of Cag on [(3)H] BP binding to calf thymus DNA and observed that Cag inhibited the [(3)H] BP binding to calf thymus DNA in the presence of microsomes prepared from animals treated with DMBA. We also studied related events like DNA synthesis and carcinogen metabolism. For assessing the DNA synthesis, thymidine kinase was used as marker. Cag caused a dose-dependent inhibition of DMBA-induced thymidine kinase activity. At the same time, Cag caused a marked inhibition of DMBA-induced aryl hydrocarbon hydroxylase (AHH) activity, an enzyme responsible for the metabolism of PAHs like BP, both in vivo and in vitro. Our study indicates that Cag exerted its antitumor effect possibly by inhibiting the carcinogen-DNA binding, which appears to be due to reduced DNA synthesis and AHH activity.
几乎所有的多环芳烃(PAHs)都需要代谢活化才能发挥其致癌活性。环境致癌物[(3)H]苯并[a]芘(BP)只有在代谢转化为反应性中间体后才具有致癌性,该中间体随后可与细胞大分子结合。二甲基苯并蒽(DMBA)与DNA的结合受到抑制通常伴随着肿瘤起始的抑制,因为大多数起始抑制剂会干扰引发剂的代谢活化。致癌物与DNA相互作用以及参与致癌多环烃代谢的酶的重要性,促使人们寻找可用于改变PAHs致癌作用的抑制剂。我们测试了天然存在的无毒化合物葡萄糖醛酸钙(Cag)对致癌物代谢和DNA相互作用的影响。Cag在体外抑制[(3)H] BP与小牛胸腺DNA的结合,在体内抑制其与表皮DNA的结合。将Cag应用于小鼠皮肤会导致[(3)H] BP与表皮DNA的结合受到剂量依赖性抑制。为了确定体内结果与体外情况的相关性,我们跟踪了Cag对[(3)H] BP与小牛胸腺DNA结合的体外作用,观察到在存在用DMBA处理的动物制备的微粒体的情况下,Cag抑制了[(3)H] BP与小牛胸腺DNA的结合。我们还研究了DNA合成和致癌物代谢等相关事件。为了评估DNA合成,使用胸苷激酶作为标志物。Cag导致DMBA诱导的胸苷激酶活性受到剂量依赖性抑制。同时,Cag在体内和体外均显著抑制了DMBA诱导的芳烃羟化酶(AHH)活性,AHH是一种负责BP等PAHs代谢的酶。我们的研究表明,Cag可能通过抑制致癌物与DNA的结合发挥其抗肿瘤作用,这似乎是由于DNA合成和AHH活性降低所致。